1.Cell researchSIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2.2016"17-1057 was used in Flow cytometry/Cell sorting to investigate whether human SIRT6 has a direct role in maintaining the homeostasis of mesodermal tissues, showing that it safeguards against oxidative stress by coactivating NRF2."Authors Pan H,Guan D,Liu X,Li J,Wang L,Wu J,Zhou J,Zhang W,Ren R,Zhang W,Li Y,Yang J,Hao Y,Yuan T,Yuan G,Wang H,Ju Z,Mao Z,Li J,Qu J,Tang F,Liu GH2.BiomaterialsMesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo.2015"17-1057 was used in Flow cytometry/Cell sorting to show that ADSCs are able to form tubular structures within fibrin gels, and may also contribute to faster wound healing."Authors Mendez JJ,Ghaedi M,Sivarapatna A,Dimitrievska S,Shao Z,Osuji CO,Steinbacher DM,Leffell DJ,Niklason LE3.Stem cells and cloning : advances and applicationsHuman adipose stem cell and ASC-derived cardiac progenitor cellular therapy improves outcomes in a murine model of myocardial infarction.2015"17-1057 was used in Flow cytometry/Cell sorting to investigate the potential use of adipose-derived stem cells."Authors Davy PM,Lye KD,Mathews J,Owens JB,Chow AY,Wong L,Moisyadi S,Allsopp RC4.EMBO molecular medicineEmbelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing.2014"17-1057 was used in Flow cytometry/Cell sorting to demonstrate a novel therapy to control pathological neoangiogenesis while sparing normal vasculature."Authors Coutelle O,Hornig-Do HT,Witt A,Andree M,Schiffmann LM,Piekarek M,Brinkmann K,Seeger JM,Liwschitz M,Miwa S,Hallek M,Krönke M,Trifunovic A,Eming SA,Wiesner RJ,Hacker UT,Kashkar H5.OncotargetFOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells.2014"17-1057 was used in Flow cytometry/Cell sorting to study the effect of fusion of mesenchymal stem cells with lung cancer cells, showing that fusion is mediated by FOXF1 and leads to a more benign state due to complementation of tumorigenic defects such as the restoration of p21 function."Authors Wei HJ,Nickoloff JA,Chen WH,Liu HY,Lo WC,Chang YT,Yang PC,Wu CW,Williams DF,Gelovani JG,Deng WP |